| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/13/1995 | WO1995011919A3 Recombinant pilc proteins, process for producing them and their use |
| 07/13/1995 | WO1995006122A3 Recombinant alternaria alternata allergenes |
| 07/13/1995 | WO1995006121A3 Recombinant cladosporium herbarum allergens |
| 07/13/1995 | CA2180644A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis |
| 07/13/1995 | CA2180465A1 Method of enhancing the human immune system |
| 07/13/1995 | CA2180426A1 Association of kinesin with sensitivity to chemotherapeutic drugs |
| 07/13/1995 | CA2180358A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/12/1995 | EP0662516A1 Novel elafin derivative |
| 07/12/1995 | EP0662513A1 Methods for preventing degradation of protein C |
| 07/12/1995 | EP0662481A1 Spiro piperidines and homologs promote release of growth hormone |
| 07/12/1995 | EP0662327A1 Use of self-incompatability receptor proteins (SLG and SRK) of plants for the treatment of allergic diseases |
| 07/12/1995 | EP0662326A2 Endoparasitical agents containing praziquantel and epsiprantel |
| 07/12/1995 | EP0662150A1 Maspin, a novel serpin with tumor suppressing activity |
| 07/12/1995 | EP0662148A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 07/12/1995 | EP0662147A1 Small cell lung carcinoma specific antibody and antigen. |
| 07/12/1995 | EP0662146A1 Dorsal tissue affecting factor and compositions |
| 07/12/1995 | EP0662139A1 Recombinant retroviral vector against felv and/or fiv |
| 07/12/1995 | EP0662138A1 Long wap promoter for mammary expression of human protein c |
| 07/12/1995 | EP0662137A1 Gene transcription and ionizing radiation: methods and compositions |
| 07/12/1995 | EP0662133A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/12/1995 | EP0662130A1 A method of producing hepatocyte growth factor and a cell line |
| 07/12/1995 | EP0662129A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/12/1995 | EP0662092A1 Activity-dependent neurotrophic factor |
| 07/12/1995 | EP0662091A1 Basophil granule proteins |
| 07/12/1995 | EP0662090A1 Peptide inhibitors of mitogenesis and motogenesis |
| 07/12/1995 | EP0662089A1 Compositions for and methods of treating cancer and autoimmune diseases |
| 07/12/1995 | EP0662088A1 Inhibitor of collagen-stimulated platelet aggregation |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0662086A1 Protein l and hybrid proteins thereof |
| 07/12/1995 | EP0662084A1 Growth hormone potentiating molecules |
| 07/12/1995 | EP0662083A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 07/12/1995 | EP0662081A1 Ureido-acetamide derivatives, preparation thereof and drugs containing same. |
| 07/12/1995 | EP0662003A1 Oligonucleotide modulation of cell adhesion |
| 07/12/1995 | EP0661997A1 Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
| 07/12/1995 | EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 07/12/1995 | EP0661995A1 Use of lectins for treatment of skin diseases. |
| 07/12/1995 | EP0661994A1 Method of prophylaxis of acute renal failure |
| 07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 07/12/1995 | EP0661991A1 Methods for treating renin-related disorders with amylin antagonists |
| 07/12/1995 | EP0661990A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 07/12/1995 | EP0661988A1 Composition and treatment with biologically active peptides and chelating agents |
| 07/12/1995 | EP0661987A1 Morphogen-induced liver regeneration |
| 07/12/1995 | EP0661986A1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 07/12/1995 | EP0661985A1 Cd8 binding domain peptides |
| 07/12/1995 | EP0661973A1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/12/1995 | EP0661967A1 Combined virustatic antimediator (covam) treatment of common colds |
| 07/12/1995 | EP0661933A1 Morphogen-enriched dietary composition |
| 07/12/1995 | EP0661930A1 Viscous liquid xylitol compositions and method for preparing same |
| 07/12/1995 | EP0661927A1 A process for producing beta-casein enriched products |
| 07/12/1995 | EP0654088A4 Novel flk-2 and analogs. |
| 07/12/1995 | EP0623027A4 Methods of terminating pregnancy. |
| 07/12/1995 | EP0615452A4 Medicament for promoting growth of mammalian nerve. |
| 07/12/1995 | EP0567586B1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 07/12/1995 | EP0550458B1 Bone growth stimulator |
| 07/12/1995 | EP0390798B1 Method and compositions relating to regression-associated antigens |
| 07/12/1995 | EP0377665B1 Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
| 07/12/1995 | EP0316319B1 Production and use of non-glycosylated IL-6 |
| 07/12/1995 | CN1105030A Erythropoietin analogs |
| 07/12/1995 | CN1104915A Compounded polyvalent staphylococcin injection |
| 07/12/1995 | CN1104902A Method for preparing multifunction health medicine by using fungus, marine alga and Chinese herbal medicine as main raw materials |
| 07/12/1995 | CN1104890A Cation-complexed polysacharides |
| 07/11/1995 | US5432270 DNA encoding tracheal antimicrobial peptides |
| 07/11/1995 | US5432264 Polypeptide with cysteine proteinase inhibitor activity, anticancer activity, and antiviral activity/effective against herper simplex/ |
| 07/11/1995 | US5432261 Motlin-like polypeptide and use thereof |
| 07/11/1995 | US5432260 Polypeptide derivatives of mannose to target glycoprotein receptors on macrophages; asthma; antiinflammatory agents; antitumor agents; immunoassay; imaging |
| 07/11/1995 | US5432202 Use of polyamines as ionic-channel regulating agents |
| 07/11/1995 | US5432186 Enzyme inhibitors |
| 07/11/1995 | US5432176 Method of retarding the progression of chronic renal failure |
| 07/11/1995 | US5432162 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA) |
| 07/11/1995 | US5432160 Contains beta-alanyl-L-glutamine |
| 07/11/1995 | US5432159 N-(α-substituted-pyridinyl)carbonyl dipeptide antihypertensive agents |
| 07/11/1995 | US5432157 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect and a use thereof |
| 07/11/1995 | US5432156 Therapeutic agent for digestive tract diseases |
| 07/11/1995 | US5432155 Conotoxins I |
| 07/11/1995 | US5432082 Expression and secretion vector in yeasts, useful for preparing heterologous proteins |
| 07/11/1995 | US5432080 Treatment of inflammation in mammals |
| 07/11/1995 | US5432076 Alteration of the interaction of a T-cell receptor with a protein-tyrosine kinase |
| 07/11/1995 | US5432062 Method of proteolytically cleaving prothrombin to produce thrombin |
| 07/11/1995 | US5431925 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 07/11/1995 | US5431909 Stabilization of human interferon |
| 07/11/1995 | US5430935 Method for repairing a combustion chamber assembly |
| 07/11/1995 | CA2005143C Stabilized hydrophobic protein formulations of g-csf |
| 07/11/1995 | CA1336269C Expression of mammalian genes at high levels in host cells |
| 07/08/1995 | CA2139612A1 Novel inhibitor |
| 07/06/1995 | WO1995018228A1 Human circulating cytokine cc-1 |
| 07/06/1995 | WO1995018227A1 Phospholipid transfer proteins |
| 07/06/1995 | WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof |
| 07/06/1995 | WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof |
| 07/06/1995 | WO1995018223A1 Gene expression control |
| 07/06/1995 | WO1995018221A1 Gene coding for adseverins |
| 07/06/1995 | WO1995018153A1 Glucagon analogs with serine replacements at position 16 having antagonistic activity |
| 07/06/1995 | WO1995018152A1 Derivatized calcitonins |
| 07/06/1995 | WO1995018151A1 Interferon glycoprotein |
| 07/06/1995 | WO1995018149A1 Novel lectin and process for producing the same |
| 07/06/1995 | WO1995018148A1 T-cell epitopes |
| 07/06/1995 | WO1995018147A1 Aureobasidins |
| 07/06/1995 | WO1995018146A1 Substituted glycerol |
| 07/06/1995 | WO1995017911A1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 07/06/1995 | WO1995017908A1 Method for selective methionine starvation of malignant cells in mammals |
| 07/06/1995 | WO1995017907A1 Methods and compositions for inhibiting thrombogenesis |